
Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugs
Keywords: ATM; ataxia-telangiectasia mutated; Epo; erythropoietin; EpoR; erythropoietin receptor; ET; essential thrombocythemia; FA; Fanconi anemia; JAK2; Janus kinase 2; MPNs; myeloproliferative neoplasms; PMF; primary myelofibrosis; PV; polycythemia vera; RT-PCR;